LivingGLP1
Study S002269

The Effect of GLP-1 in Psoriasis

ClinicalTrials.gov record

Registration

Registration
NCT01460069
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Status
COMPLETED
Enrollment
20
Start
2011-10
Primary completion
2013-05
Lead sponsor
Annesofie Faurschou
Conditions
Psoriasis
Interventions
DRUG:liraglutide; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • PASI (psoriasis area and severity index) [Baseline and after 2 months]
  • DLQI (dermatology life quality index) [Baseline and after 2 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.